G3BP1, a key protein involved in SGs development and in tumor progression by regulating the RAS, TGF-β/Smad, Src/FAK and p53 signaling pathways (Zhang et al, 2019), has been considered as a promising target. This evidence concerns the gene PTK2 and neoplasm.